Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaccination against TBE in patients using immunosuppressive drugs
2010-019438-28Phase 4Active
- Sponsor
- Mälarsjukhuset
- Start
- Mar 2010
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Tick-borne encephalitis vaccine in tick-borne encephalitis (TBE), sponsored by Mälarsjukhuset. Primary endpoints: Serum concentration of TBE antibodies after primary vaccination series and Serum concentration of TBE antibodies after booster vaccination. Started Mar 2010; status: active.
02
Drugs
Tick-borne encephalitis vaccine
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on 2010-019438-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019438-28.